Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TATAA Biocenter Expands its Digital PCR Offerings

Published: Tuesday, December 17, 2013
Last Updated: Tuesday, December 17, 2013
Bookmark and Share
Company expands its offerings with Bio-Rad’s Droplet Digital™ PCR system.

TATAA Biocenter is expanding its digital PCR offerings with Bio-Rad’s high-throughput QX200™ Droplet Digital™ PCR system (ddPCR™).

In 2007 TATAA Biocenter became the first company in Europe to provide digital PCR services to researchers and published one of the first papers that featured an application of digital PCR on a high throughput platform (Nucleic Acids Research 36: 387, 2008).

The paper discussed using digital PCR to measure intracellular mRNA gradients. TATAA also co-authored the Guidelines for Minimum Information for Publication of Quantitative Digital PCR Experiments (Clinical Chemistry 59:6, 2013). (publication names should be in italics).

“Digital PCR is most important complement to qPCR and can be used for standardization, copy number variation, and rare mutation analysis,” said Dr. Mikael Kubista, founder and CEO of TATAA Biocenter.

Dr. Kubista continued, “We have previously adopted the OpenArray and BioMark digital PCR platforms from Life Technologies and Fluidigm, which offer simultaneous measurements of qPCR and highly specific and sensitive dPCR analysis; however, with Bio-Rad’s QX200 system we can now offer dPCR in high throughput, using a much larger number of partitions. This is major strengthening of our service and training offerings.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TATAA Partners with Qlucore
TATAA Biocenter introduces partnership with Qlucore to use Qlucore Omics Explorer in its Next Generation Sequencing courses and client services.
Monday, March 09, 2015
TATAA Biocenter Awarded for Best-in-Class Gene Expression Profiling Services
Numerous accreditations from diverse institutes and customer validations lend credibility to its educational programs.
Wednesday, August 21, 2013
TATAA Strengthens Quality Assurance Program
TATAA Biocenter expands offerings using AATI’s Fragment Analyzer™ to assess RNA quality in gene expression analysis.
Tuesday, May 21, 2013
TATAA Biocenter Introduces Ingenuity Systems iReport into qPCR Workflow
TATAA Biocenter, Europe´s leading provider of genomic services using quantitative real-time polymerase PCR (qPCR), is complementing its offerings in high-throughput gene expression profiling with Ingenuity® iReport™.
Wednesday, January 23, 2013
Scientific News
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Validating the Accuracy of CRISPR-Cas9
IBS Researchers create multiplex Digenome-seq to find errors in CRISPR-Cas9 processes.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
How to Unlock Inaccessible Genes
An international team of biologists has discovered how specialized enzymes remodel the extremely condensed genetic material in the nucleus of cells in order to control which genes can be used.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!